Polychlorinated biphenyls as initiators in liver carcinogenesis: Resistant hepatocyte model

Toxicology and Applied Pharmacology

Volumn 186, Issue 1, 2003, Pages 55-62

  Espandiari, Parvaneh ^a   Glauert, Howard P ^a,b   Lehmler, Hans Joachim ^a,e   Lee, Eun Y ^a,b,c   Srinivasan, Cidambi ^d   Robertson, Larry W ^a,b,d,e  

^a Dept of Nutrition and Food Science   (United States)

^b Graduate Center for Nutritional Sciences   (United States)

^c Dept of Pathol/Laboratory Medicine ^*  (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

Altered hepatic foci; Hepatocarcinogenesis; Initiation, Solt Farber; Polychlorinated biphenyls (PCBs)

Indexed keywords

CARBON TETRACHLORIDE; EOSIN; GAMMA GLUTAMYLTRANSFERASE; HEMATOXYLIN; N (2 FLUORENYL)ACETAMIDE; POLYCHLORINATED BIPHENYL;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEEDING; HISTOPATHOLOGY; LIVER; LIVER CARCINOGENESIS; LIVER CELL; LIVER RESECTION; MALE; NONHUMAN; RAT; TISSUE LEVEL; TISSUE SECTION;

MARTES PENNANTI;

EID: 0037288745     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-008X(02)00018-2     Document Type: Article

References (62)

1. Amaro A.R., Oakley G.G., Bauer U., Spielmann H.P., Robertson L.W. Metabolic activation of PCBs to quinones reactivity toward nitrogen and sulfur nucleophiles and influence of superoxide dismutase . Chem. Res. Toxicol. 9:1996;623-629.
2. ATSDR2000. Toxicological Profile for Polychlorinated Biphenyls (PCBs). U.S. Dept. Health Services, Public Health Service.
3. Bahn A.K., Rosenwaike I., Hermann N., Grover P., Stellman J., O'Leary K. Letter melanoma after exposure to PCBs . N. Engl. J. Med. 295:1976;450.
4. Brattin W.J., Glende E.A. Jr., Recknagel R.O. Pathological mechanisms in carbon tetrachloride hepatotoxicity. J. Free Radical Biol. Med. 1:1985;27-38.
5. Brown D.P. Mortality of workers exposed to polychlorinated biphenyls an update . Arch. Environ. Health. 42:1987;333-339.
6. Buchmann A., Kunz W., Wolf C.R., Oesch F., Robertson L.W. Polychlorinated biphenyls, classified as either phenobarbital- or 3- methylcholanthrene- type inducers of cytochrome P-450, are both hepatic tumor promoters in diethylnitrosamine-initiated rats. Cancer Lett. 32:1986;243-253.
7. Buchmann A., Ziegler S., Wolf A., Robertson L.W., Durham S.K., Schwarz M. Effects of polychlorinated biphenyls in rat liver correlation between primary subcellular effects and promoting activity . Toxicol. Appl. Pharmacol. 111:1991;454-468.
8. Cadogan, J.I.G., 1962. A convenient new method of aromatic arylation. J. Chem. Soc. 4257-4258.
9. Cadogan J.I.G., Roy, D.A., and Smith, D.M., 1962. An alternative to the Sandmeyer reaction. J. Chem. Soc. 1249-1250.
10. Campbell H.A., Pitot H.C., Porter V.R., Laishes B.A. Application of quantitative stereology to the evaluation of enzyme-altered foci in rat liver. Cancer Res. 42:1982;465-472.
11. Campbell H.A., Xu Y.D., Hanigan M.H., Pitot H.C. Application of quantitative stereology to the evaluation of phenotypically heterogeneous enzyme-altered foci in the rat liver. J. Natl. Cancer Inst. 76:1986;751-767.
12. Daubeze M., Narbonne J.F. Incorporation of labeled 2,4,5,2′,4′,5′-hexachlorobiphenyl into the nuclear fraction of rat hepatocytes in vivo. Toxicology. 31:1984;315-318.
13. Deml E., Oesterle D. Sex-dependent promoting effect of polychlorinated biphenyls on enzyme-altered islands induced by diethylnitrosamine in rat liver. Carcinogenesis. 3:1982;1449-1452.
14. DiGiovanni J., Viaje A., Berry D.L., Slaga T.J., Juchau M.R. Tumor-initiating ability of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and Arochlor 1254 in the two-stage system of mouse skin carcinogenesis. Bull. Environ. Contam. Toxicol. 18:1977;552-557.
15. Dixon D., Sleight S.D., Aust S.D., Rezabek M.S. Tumor-promoting, initiating, and hepatotoxic effects of 3,3′,4,4′-tetrabromobiphenyl (34-TBB) in rats. J. Am. Coll. Toxicol. 7:1988;687-697.
16. Drinkwater N., Klotz J. Statistical models for the analysis of tumor multiplicity data. Cancer Res. 41:1981;113-119.
17. Glauert H.P., Robertson L.W., Silberhorn E.M. PCBs and tumor promotion. Robertson L.W., Hansen L.G. PCBs Recent Advances in Environmental Toxicology and Health Effects . 2001;355-371 The University Press of Kentucky, Lexington, KY.
18. Hansen L.G. The Ortho Side of PCBs Occurrence and Disposition . 1999;Kluwer Academic Publishers, Boston.
19. Hayes M.A., Safe S.H., Armstrong D., Cameron R.G. Influence of cell proliferation on initiating activity of pure polychlorinated biphenyls and complex mixtures in resistant hepatocyte in vivo assays for carcinogenicity. J. Natl. Cancer Inst. 74:1985;1037-1041.
20. Höfler F., Melzer H., Möckel H.J., Robertson L.W., Anklam E. Relationship between liquid and gas chromatographic retention behavior and calculated molecular surface area of selected polyhalogenated biphenyls. J. Agric. Food Chem. 36:1988;961-965.
21. Jensen R.K., Sleight S.D., Aust S.D. Effect of varying the length of exposure to polybrominated biphenyls on the development of gamma-glutamyl transpeptidase enzyme-altered foci. Carcinogenesis. 5:1984;63-66.
22. Lang V. Polychlorinated biphenyls in the environment. J. Chromatogr. 595:1992;1-43.
23. Liss, G.,1989. Mortality and cancer morbidity among transformer manufacturing workers, Ferranti-Packard Transformers Ltd, St. Catherines, in: Policy and Regulation Branch. Health Studies Service, Ontario Ministry of Labor, Toronto, Ontario, Canada.
24. Loomis D., Browning S.R., Schenck A.P., Gregory E., Savitz D.A. Cancer mortality among electric utility workers exposed to polychlorinated biphenyls. Occup. Environ. Med. 54:1997;720-728.
25. Ludewig G. Cancer Initiation by PCBs. Robertson L.W., Hansen L.G. PCBs Recent Advances in Environmental Toxicology and Health Effects . 2001;337-354 The University Press of Kentucky, Lexington, KY.
26. Maronpot R.R., Montgomery C.A. Jr., Boorman G.A., McConnell E.E. National Toxicology Program nomenclature for hepatoproliferative lesions of rats. Toxicol. Pathol. 14:1986;263-273.
27. Mayes B.A., McConnell E.E., Neal B.H., Brunner M.J., Hamilton S.B., Sullivan T.M., Peters A.C., Ryan M.J., Toft J.D., Singer A.W., Brown J.F. Jr., Menton R.G., Moore J.A. Comparative carcinogenicity in Sprague-Dawley rats of the polychlorinated biphenyl mixtures Aroclors 1016, 1242, 1254, and 1260. Toxicol. Sci. 41:1998;62-76.
28. McLean M.R., Bauer U., Amaro A.R., Robertson L.W. Identification of catechol and hydroquinone metabolites of 4-monochlorobiphenyl. Chem. Res. Toxicol. 9:1996;158-164.
29. 32P-postlabeling technique. Chem. Res. Toxicol. 9:1996;165-171.
30. McLean M.R., Twaroski T.P., Robertson L.W. Redox cycling of 2-(x′-mono, -di, -trichlorophenyl)-1,4-benzoquinones, oxidation products of polychlorinated biphenyls. Arch. Biochem. Biophys. 376:2000;449-455.
31. Mills R.A., Millis C.D., Dannan G.A., Guengerich F.P., Aust S.D. Studies on the structure-activity relationships for the metabolism of polybrominated biphenyls by rat liver microsomes. Toxicol. Appl. Pharmacol. 78:1985;96-104.
32. Mönig J., Asmus K.-D., Robertson L.W., Oesch F. Polychlorinated biphenyl radical cations a pulse radiolysis investigation . J. Chem. Soc. Perkin Trans. 2:1986;891-896.
33. Morales N.M., Matthews H.B. In vivo binding of 2,3,6,2′,3′,6′- hexachlorobiphenyl and 2,4,5,2′,4′,5′-hexachlorobiphenyl to mouse liver macromolecules. Chem-Biol. Interact. 27:1979;99-110.
34. Narbonne J.F., Daubeze M. In vitro binding of hexachlorobiphenyl to DNA and proteins. Toxicology. 16:1980;173-175.
35. Oakley G.G., Devanaboyina U., Robertson L.W., Gupta R.C. Oxidative DNA damage induced by activation of polychlorinated biphenyls (PCBs) implications for PCB-induced oxidative stress in breast cancer . Chem. Res. Toxicol. 9:1996;1285-1292.
36. 32P-postlabeling. Carcinogenesis. 17:1996;109-114.
37. Oakley G.G., Roe A.L., Blouin R.A., Twaroski T.P., Ganguly T.C., Vore M., Lehmler H.J., Robertson L.W. 2,4,4′-Trichlorobiphenyl increases STAT5 transcriptional activity. Mol. Carcinog. 30:2001;199-208.
38. Oesterle D., Deml E. Promoting effect of polychlorinated biphenyls on development of enzyme-altered islands in livers of weanling and adult rats. J. Cancer Res. Clin. Oncol. 5:1983;141-147.
39. Oesterle D., Deml E. Dose-dependent promoting effect of polychlorinated biphenyls on enzyme-altered islands in livers of adult and weanling rats. Carcinogenesis. 5:1984;351-355.
40. Oesterle D., Deml E. Enhancing effect of co-administration of polychlorinated biphenyls and diethylnitrosamine on enzyme-altered islands induced by diethylnitrosamine in rat liver. Carcinogenesis. 7:1986;1697-1700.
41. Pereg D., Tampal N., Espandiari P., Robertson L.W. Distribution and macromolecular binding of benzo[a]pyrene and two polychlorinated biphenyl congeners in female mice. Chem.-Biol. Interact. 137:2001;243-258.
42. Rao C.V., Banerji S.A. Effect of feeding polychlorinated biphenyl (Aroclor 1260) on hepatic enzymes of rats. Indian J. Exp. Biol. 28:1990;149-151.
43. Robertson L.W. Do structure-activity relationships for the acute toxicity of PCBs and PBBs also apply for the induction of hepatocellular carcinoma? Environ. Toxicol. Chem. 10:1991;715-726.
44. Robertson L.W., Hansen L.G. PCBs Recent Advances in Environmental Toxicology and Health Effects . 2001;The University Press of Kentucky, Lexington, KY.
45. Rutenburg A.M., Kim H., Fischbein J.W., Hanker J.S., Wasserkrug H.L., Seligman A.M. Histochemical and ultrastructural demonstration of gamma-glutamyl transpeptidase activity. J. Histochem. Cytochem. 17:1969;517-526.
46. Safe S. Polychlorinated biphenyls (PCBs) and polybrominated biphenyls (PBBs) biochemistry, toxicology, and mechanism of action . Crit. Rev. Toxicol. 13:1984;319-395.
47. Safe S. Polychlorinated biphenyls (PCBs) mutagenicity and carcinogenicity . Mutat. Res. 220:1989;31-47.
48. Safe S. Polychlorinated biphenyls (PCBs) environmental impact, biochemical and toxic responses, and implications for risk assessment . Crit. Rev. Toxicol. 24:1994;87-149.
49. Sargent L., Dragan Y.P., Erickson C., Laufer C.J., Pitot H.C. Study of the separate and combined effects of the non-planar 2,5,2′,5′- and the planar 3,4,3′,4′-tetrachlorobiphenyl in liver and lymphocytes in vivo. Carcinogenesis. 12:1991;793-800.
50. Sargent L., Roloff B., Meisner L. In vitro chromosome damage due to PCB interactions. Mutat. Res. 224:1989;79-88.
51. Sargent L.M., Sattler G.L., Roloff B., Xu Y.H., Sattler C.A., Meisner L., Pitot H.C. Ploidy and specific karyotypic changes during promotion with phenobarbital, 2,5,2′,5′-tetrachlorobiphenyl, and/or 3,4,3′4′-tetrachlorobiphenyl in rat liver. Cancer Res. 52:1992;955-962.
52. Semple-Roberts E., Hayes M.A., Armstrong D., Becker R.A., Racz W.J., Farber E. Alternative methods of selecting rat hepatocellular nodules resistant to 2-acetylaminofluorene. Int. J. Cancer. 40:1987;643-645.
53. Silberhorn E.M., Glauert H.P., Robertson L.W. Carcinogenicity of polyhalogenated biphenyls PCBs and PBBs . Crit. Rev. Toxicol. 20:1990;440-496.
54. Sinks T., Steele G., Smith A.B., Watkins K., Shults R.A. Mortality among workers exposed to polychlorinated biphenyls. Am. J. Epidemiol. 136:1992;389-398.
55. Solt D.B., Medline A., Farber E. Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis. Am. J. Pathol. 88:1977;595-618.
56. Srinivasan A., Lehmler H.J., Robertson L.W., Ludewig G. Production of DNA strand breaks in vitro and reactive oxygen species in vitro and in HL-60 cells by PCB metabolites. Toxicol. Sci. 60:2001;92-102.
57. Sundstrom G., Hutzinger O., Safe S. The metabolism of chlorobiphenyls a review . Chemosphere. 5:1976;267-298.
58. Tampal N., Myers S., Pereg D., Robertson L.W. Interaction of 4- chlorobiphenyl and 3,3′,4,4′-tetrachlorobiphenyl with hemoglobin. Robertson L.W., Hansen L.G. PCBs Recent Advances in Environmental Toxicology and Health Effects . 2001;391-393 The University Press of Kentucky, Lexington, KY.
59. Tanabe S. PCB problems in the future foresight from current knowledge . Environ. Pollut. 50:1988;5-28.
60. Tsuda H., Lee G., Farber E. Induction of resistant hepatocytes as a new principle for a possible short-term in vivo test for carcinogens. Cancer Res. 40:1980;1157-1164.
61. Wiencke J.K., Thurston S.W., Kelsey K.T., Varkonyi A., Wain J.C., Mark E.J., Christiani D.C. Early age at smoking initiation and tobacco carcinogen damage in the lung. J. Natl. Cancer Inst. 91:1999;614-619.
62. Xu Y.H., Dragan Y.P., Campbell H.A., Pitot H.C. STEREO a program on a PC-Windows 95 platform for recording and evaluating quantitative stereologic investigations of multistage hepatocarcinogenesis in rodents . Comput. Methods Programs Biomed. 56:1998;49-63.